Phio Pharmaceuticals Corp (NASDAQ: PHIO) on Friday, soared 5.45% from the previous trading day, before settling in for the closing price of $1.65. Within the past 52 weeks, PHIO’s price has moved between $0.97 and $9.79.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -20.00% over the last five years. The company achieved an average annual earnings per share of 147.36%. With a float of $4.23 million, this company’s outstanding shares have now reached $4.78 million.
The firm has a total of 5 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Phio Pharmaceuticals Corp (PHIO) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Phio Pharmaceuticals Corp is 11.45%, while institutional ownership is 5.13%. The most recent insider transaction that took place on Jun 07 ’24, was worth 740. In this transaction President & CEO of this company bought 1,000 shares at a rate of $0.74, taking the stock ownership to the 20,990 shares. Before that another transaction happened on Jun 06 ’24, when Company’s President & CEO bought 1,000 for $0.75, making the entire transaction worth $750. This insider now owns 19,990 shares in total.
Phio Pharmaceuticals Corp (PHIO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 147.36% per share during the next fiscal year.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) Trading Performance Indicators
Phio Pharmaceuticals Corp (PHIO) is currently performing well based on its current performance indicators. A quick ratio of 5.65 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -10.33
Technical Analysis of Phio Pharmaceuticals Corp (PHIO)
Analysing the last 5-days average volume posted by the [Phio Pharmaceuticals Corp, PHIO], we can find that recorded value of 32.0 million was better than the volume posted last year of 7.8 million. As of the previous 9 days, the stock’s Stochastic %D was 38.26%. Additionally, its Average True Range was 0.24.
During the past 100 days, Phio Pharmaceuticals Corp’s (PHIO) raw stochastic average was set at 8.73%, which indicates a significant decrease from 43.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 186.45% in the past 14 days, which was lower than the 272.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4931, while its 200-day Moving Average is $2.7224. Now, the first resistance to watch is $1.8900. This is followed by the second major resistance level at $2.0400. The third major resistance level sits at $2.2100. If the price goes on to break the first support level at $1.5700, it is likely to go to the next support level at $1.4000. Should the price break the second support level, the third support level stands at $1.2500.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) Key Stats
Market capitalization of the company is 8.32 million based on 4,778K outstanding shares. Right now, sales total 0 K and income totals -7,150 K. The company made 0 K in profit during its latest quarter, and -1,630 K in sales during its previous quarter.
